Chromocell Therapeutics Stock (AMEX: CHRO) stock price, news, charts, stock research, profile.
Open | $1.550 |
Close | $1.500 |
Volume / Avg. | 9.681K / 34.344K |
Day Range | 1.490 - 1.660 |
52 Wk Range | 1.210 - 6.000 |
Market Cap | $9.169M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 33 |
Short Interest | 0.06% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Chromocell Therapeutics (AMEX: CHRO) through any online brokerage.
Other companies in Chromocell Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX) and NuCana (NASDAQ:NCNA).
There is no analysis for Chromocell Therapeutics.
The stock price for Chromocell Therapeutics (AMEX: CHRO) is $1.56 last updated Today at April 25, 2024 at 12:30 PM EDT.
There are no upcoming dividends for Chromocell Therapeutics.
Chromocell Therapeutics’s Q1 earnings are confirmed for Monday, May 20, 2024.
There is no upcoming split for Chromocell Therapeutics.
Chromocell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.